| pubmed-article:9123926 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0220847 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0042749 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0166049 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0005795 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0086409 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C2347026 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0370003 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0003320 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0332464 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C1521797 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C2737043 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0205473 | lld:lifeskim |
| pubmed-article:9123926 | lifeskim:mentions | umls-concept:C0205258 | lld:lifeskim |
| pubmed-article:9123926 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9123926 | pubmed:dateCreated | 1997-4-22 | lld:pubmed |
| pubmed-article:9123926 | pubmed:abstractText | The detection of antibody to the second envelope protein (E2) of the hepatitis C virus (HCV) has been hampered by the lack of suitable antigens. A previously described E2 recombinant antigen (CHO-E2) expressed as a non-fused, highly glycosylated protein in mammalian cells was used to detect specific antibody (anti-E2) in samples from blood donors and viraemic patients showing positive or indeterminate results for anti-HCV after a wide serological study. Anti-E2 was detected in 50-75% of the donors positive for anti-HCV, 80% of viraemic immunocompetent patients with anti-NS3 alone and 28% of non-viraemic donors with anticore alone. In donors with anti-NS3 (15 samples) or anti-NS4 (51 samples) alone, anti-E2 was found occasionally (3 cases). Moreover, two anti-E2-positive samples from viraemic patients were misidentified by some commercial assays for screening anti-HCV. These results suggest that testing for anti-E2 may be useful for improving the performance of the current assays for anti-HCV screening and confirmation. | lld:pubmed |
| pubmed-article:9123926 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9123926 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123926 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9123926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123926 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9123926 | pubmed:issn | 0042-9007 | lld:pubmed |
| pubmed-article:9123926 | pubmed:author | pubmed-author:LópezJ AJA | lld:pubmed |
| pubmed-article:9123926 | pubmed:author | pubmed-author:LeónPP | lld:pubmed |
| pubmed-article:9123926 | pubmed:author | pubmed-author:DomingoC JCJ | lld:pubmed |
| pubmed-article:9123926 | pubmed:author | pubmed-author:EchevarriaJ... | lld:pubmed |
| pubmed-article:9123926 | pubmed:author | pubmed-author:ElolaCC | lld:pubmed |
| pubmed-article:9123926 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9123926 | pubmed:volume | 70 | lld:pubmed |
| pubmed-article:9123926 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9123926 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9123926 | pubmed:pagination | 213-6 | lld:pubmed |
| pubmed-article:9123926 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:meshHeading | pubmed-meshheading:9123926-... | lld:pubmed |
| pubmed-article:9123926 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:9123926 | pubmed:articleTitle | Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV. | lld:pubmed |
| pubmed-article:9123926 | pubmed:affiliation | Department of Diagnosis, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain. | lld:pubmed |
| pubmed-article:9123926 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9123926 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9123926 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9123926 | lld:pubmed |
